ADM and glycogen storage disease VI: Given that blood–brain barrier dysfunction represents a critical initiating event in neuroinflammatory disease progression, including those associated with viral encephalitis, ADM signaling may offer therapeutic potential by stabilizing endothelial tight junctions and reducing microglial activation.